Policy | September 28, 2024
India releases revised operational guidelines of non-alcoholic fatty liver disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Pfizer's decision is based on the totality of clinical data
New Phase II data show vast majority of patients experiencing no relapses or disability progression
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Currently, Sharma is a part of the Philippines Country Leadership Team as Business Unit Head Respiratory & Immunology
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Subscribe To Our Newsletter & Stay Updated
